Activity of venetoclax-based therapy in chronic myelomonocytic leukemia

被引:28
作者
Montalban-Bravo, Guillermo [1 ]
Hammond, Danielle [1 ]
DiNardo, Courtney D. [1 ]
Konopleva, Marina [1 ]
Borthakur, Gautam [1 ]
Short, Nicholas J. [1 ]
Ramos-Perez, Jorge [1 ]
Guerra, Veronica [1 ]
Kanagal-Shamanna, Rashmi [2 ]
Naqvi, Kiran [1 ]
Sasaki, Koji [1 ]
Jabbour, Elias [1 ]
Pemmaraju, Naveen [1 ]
Kadia, Tapan M. [1 ]
Ravandi, Farhad [1 ]
Daver, Naval [1 ]
Estrov, Zeev [1 ]
Pierce, Sherry [1 ]
Kantarjian, Hagop [1 ]
Garcia-Manero, Guillermo [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
关键词
WORLD-HEALTH-ORGANIZATION; MYELOID NEOPLASMS; CLASSIFICATION; REVISION;
D O I
10.1038/s41375-021-01240-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1494 / 1499
页数:6
相关论文
共 50 条
[31]   Features of TP53-mutated patients with chronic myelomonocytic leukemia in a national (ABCMML) and international cohort (cBIOPORTAL) [J].
Grass, Magdalena ;
Geissler, Klaus .
WIENER MEDIZINISCHE WOCHENSCHRIFT, 2025,
[32]   Features of RUNX1-mutated patients with chronic myelomonocytic leukemia in a national (ABCMML) and international cohort (cBioPortal) [J].
Bayat, Sarah ;
Geissler, Klaus .
WIENER MEDIZINISCHE WOCHENSCHRIFT, 2025,
[33]   Genomic determinants of chronic myelomonocytic leukemia [J].
Patel, B. J. ;
Przychodzen, B. ;
Thota, S. ;
Radivoyevitch, T. ;
Visconte, V. ;
Kuzmanovic, T. ;
Clemente, M. ;
Hirsch, C. ;
Morawski, A. ;
Souaid, R. ;
Saygin, C. ;
Nazha, A. ;
Demarest, B. ;
LaFramboise, T. ;
Sakaguchi, H. ;
Kojima, S. ;
Carraway, H. E. ;
Ogawa, S. ;
Makishima, H. ;
Sekeres, M. A. ;
Maciejewski, J. P. .
LEUKEMIA, 2017, 31 (12) :2815-2823
[34]   Models of Prognostication in Chronic Myelomonocytic Leukemia [J].
Francesco Onida .
Current Hematologic Malignancy Reports, 2017, 12 :513-521
[35]   Models of Prognostication in Chronic Myelomonocytic Leukemia [J].
Onida, Francesco .
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (06) :513-521
[36]   Chronic Myelomonocytic Leukemia and Atypical Chronic Myeloid Leukemia: A National Analysis [J].
Vardell, Victoria A. ;
Ose, Jennifer ;
Rets, Anton, V ;
Tantravahi, Srinivas K. ;
Patel, Ami B. .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (12) :843-851
[37]   Hypomethylating agents in the treatment of chronic myelomonocytic leukemia: a meta-analysis and systematic review [J].
Xu, Ruohao ;
Li, Minming ;
Wu, Ping ;
Deng, Chengxin ;
Geng, Suxia ;
Huang, Xin ;
Weng, Jianyu ;
Du, Xin .
HEMATOLOGY, 2021, 26 (01) :312-320
[38]   Real-world data on efficacy and safety of azacitidine therapy in chronic myelomonocytic leukemia in China: results from a multicenter, retrospective study [J].
Xu, Yu ;
Guo, Rong ;
Miao, Miao ;
Zhang, Guangsen ;
Lan, Jianping ;
Jin, Jie .
INVESTIGATIONAL NEW DRUGS, 2022, 40 (05) :1117-1124
[39]   A new approach for diagnosing chronic myelomonocytic leukemia using structural parameters of Sysmex XNTM analyzers in routine laboratory practice [J].
Schillinger, Francoise ;
Sourdeau, Elise ;
Boubaya, Marouane ;
Baseggio, Lucile ;
Clauser, Sylvain ;
Cornet, Edouard ;
Debord, Camille ;
Defour, Jean-Pierre ;
Dubois, Frederique ;
Eveillard, Marion ;
Galoisy, Anne-Cecile ;
Geay, Marie-Odile ;
Mullier, Francois ;
Nivaggioni, Vanessa ;
Soenen, Valerie ;
Morel, Pascal ;
Garnache-Ottou, Francine ;
Ronez, Emily ;
Bardet, Valerie ;
Deconinck, Eric .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2018, 78 (03) :159-164
[40]   Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents [J].
Alfonso, Ana ;
Montalban-Bravo, Guillermo ;
Takahashi, Koichi ;
Jabbour, Elias J. ;
Kadia, Tapan ;
Ravandi, Farhad ;
Cortes, Jorge ;
Estrov, Zeev ;
Borthakur, Gautam ;
Pemmaraju, Naveen ;
Konopleva, Marina ;
Bueso-Ramos, Carlos ;
Pierce, Sherry ;
Kantarjian, Hagop ;
Garcia-Manero, Guillermo .
AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (07) :599-606